StreetInsider.com News Articles

UNLOCKD reports 76% revenue growth at Ancient Extracts subsidiary in May

Thu, 11 Jun 2026 07:31:23 -0400

BitFrontier Capital Holdings Inc. (OTCID: BFCH), operating as UNLOCKD Inc., reported preliminary revenue growth at its recently acquired subsidiary Ancient Extracts USA for May 2026.

The company stated that Ancient Extracts generated approximately $22,344 in preliminary May revenue, compared to approximately $12,670 in April, representing 76% month-over-month growth according to the press release.

UNLOCKD noted that operations at Ancient Extracts commenced under its ownership during the middle of May following the acquisition closing, meaning the reported May revenue reflects only a partial month under company ownership.

Ancient Extracts received a purchase order on June 2, 2026, representing approximately $58,823 in retail product value,

UNLOCKD Reports 76% Month-Over-Month Revenue Growth at Ancient Extracts Following Acquisition

Thu, 11 Jun 2026 07:30:00 -0400

Preliminary May Revenue Reaches Approximately $22,344; Company Receives Purchase Order Representing Approximately $58,823 in Retail Product Value

LANCASTER, PA - June 11, 2026 (NEWMEDIAWIRE) - BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc. ("UNLOCKD" or the "Company"), today provided a commercialization update regarding its recently acquired operating subsidiary, VerdaGenix LLC d/b/a Ancient Extracts USA ("Ancient Extracts"), highlighting encouraging early operating results and continued progress in the Company's transition toward a revenue-generating wellness platform.

Management has completed its preliminary review of Ancient Extracts operating results for May 2026.

Preliminary April 2026 revenue was approximately $12,670, while preliminary May

UNLOCKD Reports 76% Month-Over-Month Revenue Growth at Ancient Extracts Following Acquisition

Thu, 11 Jun 2026 07:30:00 -0400

Preliminary May Revenue Reaches Approximately $22,344; Company Receives Purchase Order Representing Approximately $58,823 in Retail Product Value

Management has completed its preliminary review of Ancient Extracts operating results for May 2026.

Preliminary April 2026 revenue was approximately $12,670, while preliminary May

BFCH completes Ancient Extracts USA acquisition for wellness platform

Tue, 19 May 2026 06:31:29 -0400

BitFrontier Capital Holdings Inc. (OTCID: BFCH) announced it completed the acquisition of VerdaGenix LLC, which operates the Ancient Extracts USA wellness platform. Ancient Extracts USA becomes a wholly owned subsidiary of BFCH following the transaction closure.

The acquired company brings direct-to-consumer infrastructure, commercial operations, proprietary formulations, supplier relationships, inventory, fulfillment capabilities, and a catalog of more than 20 wellness products. BFCH operates under the business name UNLOCKD Inc.

BFCH eliminated more than $2 million in convertible debt obligations over the past year and acquired the EVERMIND intellectual property platform. The company received a legal opinion from securities counsel stating BFCH does not

BFCH Closes Ancient Extracts USA Acquisition, Accelerating UNLOCKD's Transition Into a Scalable Consumer Wellness Operating Platform

Tue, 19 May 2026 06:30:00 -0400

Company Advances Commercial Expansion Strategy Across DTC and Retail Channels as BFCH Continues Executing Long-Term Platform Growth Strategy

LANCASTER, PA - May 19, 2026 (NEWMEDIAWIRE) - BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc. (BFCH or the Company), today announced the successful closing of its previously announced acquisition of VerdaGenix, LLC, owner and operator of the Ancient Extracts USA wellness platform, pursuant to definitive transaction documents executed and finalized by the parties.

With the closing complete, Ancient Extracts USA officially becomes a wholly owned subsidiary of BFCH, adding an established operating wellness platform featuring active direct-to-consumer infrastructure,

BFCH Closes Ancient Extracts USA Acquisition, Accelerating UNLOCKD's Transition Into a Scalable Consumer Wellness Operating Platform

Tue, 19 May 2026 06:30:00 -0400

Company Advances Commercial Expansion Strategy Across DTC and Retail Channels as BFCH Continues Executing Long-Term Platform Growth Strategy

UNLOCKD Inc. (OTCID: BFCH) Nears Key Milestones in Brand Partnership, Equity Funding, and Digital-Asset Integration

Tue, 11 Nov 2025 07:39:00 -0400

LANCASTER, PA - November 11, 2025 (NEWMEDIAWIRE) - BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc. , today issued a corporate update outlining progress across its near-term execution priorities, including the final phase of its equity seed round, the expected closing of a previously disclosed Letter of Intent (LOI) with a global consumer brand, and the continued modernization of its balance-sheet and digital-asset infrastructure.

LOI approaching binding stage

On October 31, 2025, UNLOCKD executed a Letter of Intent (LOI) with a well-known global consumer-brand partner to pursue a strategic commercial collaboration within the wellness and functional-beverage sector.

UNLOCKD Inc. (OTCID: BFCH) Nears Key Milestones in Brand Partnership, Equity Funding, and Digital-Asset Integration

Tue, 11 Nov 2025 07:39:00 -0400

LOI approaching binding stage

UNLOCKD Inc. (OTCID: BFCH) Nears Key Milestones in Brand Partnership, Equity Funding, and Digital-Asset Integration

Tue, 11 Nov 2025 07:39:00 -0400

LOI approaching binding stage

UNLOCKD Inc. (OTCID: BFCH) - From Reset to Execution: Building the Public Platform for High-Growth Consumer Brands

Mon, 20 Oct 2025 07:39:00 -0400

LANCASTER, PA - October 20, 2025 (NEWMEDIAWIRE) - BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., today released a shareholder update from Chairman and CEO Dr. Jordan P. Balencic, outlining its execution roadmap for the remainder of Q4 2025 and the Companys strategy to establish a next-generation public platform for scaling high-growth consumer brands.

Corporate Name Transition

During its restructuring period, the Company temporarily operated under the name EVERMIND Holdings, Inc. as an unofficial d/b/a - a functional placeholder keeping the platform operational while legacy cleanup activities occurred. Following this period of stabilization, the Company solidified its

Form 3 BITFRONTIER CAPITAL HOLD For: Sep 05 Filed by: Balencic Jordan Paul

Fri, 05 Sep 2025 15:12:00 -0400

si-local-file:///var/storage/secattach/20250905/25303003.html

Form 3 BITFRONTIER CAPITAL HOLD For: Sep 05 Filed by: Balencic Jordan Paul

Fri, 05 Sep 2025 15:12:00 -0400

si-local-file:///var/storage/secattach/20250905/25303003.html

BFCH to acquire cognitive beverage company for $4 million

Mon, 04 Aug 2025 07:10:31 -0400

BitFrontier Capital Holdings Inc. (OTC: BFCH) announced it signed a binding letter of intent to acquire ERApeutics LLC, developer of the EVERMIND functional beverage platform, for $4 million in equity.

The transaction involves issuing 400 million restricted common shares at $0.01 per share. EVERMIND is described as a physician-formulated, plant-based protein shake designed for cognitive health benefits.

ERApeutics previously raised $1.67 million in equity capital at a $4 million pre-money valuation from investors including two institutional backers. The acquisition includes six proprietary formulations, research and development pipeline, trademarks, and an e-commerce platform.

"This isn't just a beverage asset - it's a platform," said

BFCH to acquire cognitive beverage company for $4 million

Mon, 04 Aug 2025 07:10:31 -0400

"This isn't just a beverage asset - it's a platform," said

BFCH Signs Binding LOI to Acquire EVERMIND(TM) Beverage - A Science-Supported Cognitive Health Platform

Mon, 04 Aug 2025 07:10:00 -0400

Accretive Acquisition Adds IP-backed Consumer Brand, Strengthens Balance Sheet, and Reinforces $0.01 Equity Benchmark Ahead of Eventual Uplisting and Expanded Capital Strategy

CRESTVIEW, FL - August 4, 2025 (NEWMEDIAWIRE) - BitFrontier Capital Holdings, Inc. (OTC: BFCH), doing business as EVERMIND Holdings, Inc. (EVERMIND), today announced it has signed a binding Letter of Intent (LOI) to acquire ERApeutics, LLC, the developer of EVERMINDTM - a physician-formulated functional beverage platform for cognitive health.

Designed as a creamy, plant-based protein shake, EVERMINDTM delivers both short- and long-term brain health benefits in one convenient daily ritual. The brand is shelf-stable, science-supported, and ready for

BFCH Signs Binding LOI to Acquire EVERMIND(TM) Beverage - A Science-Supported Cognitive Health Platform

Mon, 04 Aug 2025 07:10:00 -0400

Accretive Acquisition Adds IP-backed Consumer Brand, Strengthens Balance Sheet, and Reinforces $0.01 Equity Benchmark Ahead of Eventual Uplisting and Expanded Capital Strategy

BFCH Unveils Business Plan and Platform Vision Following Leadership Transition and Structural Reset

Wed, 30 Jul 2025 07:09:00 -0400

CRESTVIEW, FL - July 30, 2025 (NEWMEDIAWIRE) - BitFrontier Capital Holdings, Inc. (OTC: BFCH), doing business as EVERMIND Holdings, Inc. , today announced the publication of its updated strategic business plan following a recent change in control, leadership transition, and material restructuring of its capital base.

On July 21, 2025, physician-entrepreneur Dr. Jordan P. Balencic was appointed Chief Executive Officer following a formal change of control and board resolution. As the Companys new controlling shareholder and CEO, Dr. Balencic brings a long-term ownership mindset and has moved quickly to realign BFCHs corporate strategy, strengthen its financial position, and begin rebuilding

BFCH Unveils Business Plan and Platform Vision Following Leadership Transition and Structural Reset

Wed, 30 Jul 2025 07:09:00 -0400

BFCH Eliminates $2M in Convertible Debt at 2,400% Premium to Market - Unlocking a Clean Path Forward

Mon, 28 Jul 2025 07:10:00 -0400

CRESTVIEW, FL - July 28, 2025 (NEWMEDIAWIRE) - BitFrontier Capital Holdings, Inc. (OTC: BFCH) today announced the full retirement of all outstanding legacy convertible debt obligations, eliminating over $2 million in overhang and setting the stage for a transformative new chapter under the Companys recently appointed CEO, Dr. Jordan P. Balencic.

The debt is redeemable to common equity at $0.01 per share, a level that represents a premium of approximately 2,400% above the current market price , and reflects the Company's deliberate restructuring strategy and its focus on restoring shareholder trust through responsible governance.

Pursuant to the terms of the

BFCH Eliminates $2M in Convertible Debt at 2,400% Premium to Market - Unlocking a Clean Path Forward

Mon, 28 Jul 2025 07:10:00 -0400

Pursuant to the terms of the

BitFrontier Capital Holdings, Inc. (OTC: BFCH) Appoints Dr. Jordan P. Balencic as CEO to Lead Strategic Corporate Turnaround

Thu, 24 Jul 2025 07:30:00 -0400

CRESTVIEW, FL - July 24, 2025 (NEWMEDIAWIRE) - BitFrontier Capital Holdings, Inc. (OTC: BFCH), a public company historically engaged in cryptocurrency mining and hosting services, today announced the appointment of Dr. Jordan P. Balencic as its Chief Executive Officer. This leadership transition marks the beginning of a comprehensive turnaround strategy aimed at realigning the Companys capital structure, business model, and shareholder value proposition.

Dr. Balencic is a physician entrepreneur and public company advisor with over a decade of experience in the health and wellness industry. He has served on the boards of other OTC and small-cap issuers and brings expertise

BitFrontier Capital Holdings, Inc. (OTC: BFCH) Appoints Dr. Jordan P. Balencic as CEO to Lead Strategic Corporate Turnaround

Thu, 24 Jul 2025 07:30:00 -0400